{
    "Clinical Trial ID": "NCT03618017",
    "Intervention": [
        "INTERVENTION 1: ",
        "  Recruitment Population",
        "  Pre-randomization recruitment and enrollment"
    ],
    "Eligibility": [
        "Inclusion Criteria:",
        "  Diagnosed with early Stage (0-IIB) breast cancer",
        "  Must be a patient of a University of Michigan Breast Cancer Oncologist",
        "  Must be completing primary cancer treatment and transitioning into survivorship",
        "  Must be able to speak, read and write in English",
        "  Must have access and the ability to use the internet",
        "Exclusion Criteria:",
        "  Diagnosed with stage III or IV breast cancer",
        "  Unable to speak, read, and write in English"
    ],
    "Results": [
        "Outcome Measurement: ",
        "  Number of Breast Cancer Patients Successfully Recruited to Participate in the Study",
        "  We anticipate a response rate of 80% enrollment (n=60). We will assess the number of patients successfully recruited who enroll and complete the baseline survey.",
        "  Time frame: At baseline survey",
        "Results 1: ",
        "  Arm/Group Title: Recruitment Population",
        "  Arm/Group Description: Pre-randomization recruitment and enrollment",
        "  Overall Number of Participants Analyzed: 160",
        "  Measure Type: Count of Participants",
        "  Unit of Measure: Participants  66  41.3%"
    ],
    "Adverse Events": [
        "Adverse Events 1:",
        "  Total: 0/33 (0.00%)"
    ]
}